MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference
DAIC
FEBRUARY 9, 2024
The data were presented yesterday at the 2024 International Stroke Conference (AZ), a premier event featuring global thought leaders and dedicated to the latest in the science and treatment of cerebrovascular disease and brain health. A total of 17 sites and 123 patients participated across the United States and France.
Let's personalize your content